Thyroidectomy Clinical Trials

Clinical trials related to Thyroidectomy Procedure

Contribution of Indocyanine Green Angiography in the Detection of Parathyroids and the Prevention of Hypoparathyroidism Post Total Thyroidectomy

Who is this study for? Adults having to undergo a total thyroidectomy
What treatments are being studied? Indocyanine green
Status: Recruiting
Location: See location...
Intervention Type: Drug, Procedure
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

* Hypoparathyroidism is the most common complication after a total thyroidectomy surgery. It becomes permanent after 6 months. * Untreated permanent hypoparathyroidism is a source of numerous complications in general and therefore requires lifelong replacement therapy resulting in a significant deterioration in quality of life. * The intraoperative use of indocyanine green (ICG) angiography has recently been described as a reliable means of detecting parathyroidism and predicting the risk of postoperative hypoparathyroidism. * This use could prove to be a way to preserve parathyroid in vivo and thus reduce post-operative hypoparathyroidism rates.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patient having to undergo a total thyroidectomy

• Signed consent

• Patient beneficiary of a social security regimen

Locations
Other Locations
France
CHRU de Brest
RECRUITING
Brest
Contact Information
Primary
Jean-Christophe LECLERE, PhD
jean-christophe.leclere@chu-brest.fr
0298223630
Time Frame
Start Date: 2021-06-22
Estimated Completion Date: 2027-06-22
Participants
Target number of participants: 242
Treatments
Experimental: ICG group
Patient receiving 2 or 3 intraoperative injections of indocyanine green.
Other: Control group
Patient benefiting from the traditional surgical act
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Brest

This content was sourced from clinicaltrials.gov